Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PD-1/L1
Pharma
AACR: Keytruda delivers an industry first in head and neck cancer
While Keytruda stands to become a new standard of care in resectable head and neck cancer, some questions remain.
Angus Liu
Apr 28, 2025 1:28pm
Akeso CEO tries to reset expectations of bispecific's OS readout
Apr 28, 2025 6:50am
Summit stock falls as Akeso shares bispecific OS data vs. Keytruda
Apr 25, 2025 4:02pm
Akeso’s Anniko enters crowded US PD-1 market
Apr 25, 2025 10:55am
Akeso's fast-rising ivonescimab scores 3rd lung cancer trial win
Apr 23, 2025 11:30am
BMS follows Roche, AstraZeneca into first-line liver cancer
Apr 11, 2025 1:53pm
.jpg?VersionId=5HoajupHCiKKFzt_zOi.f2WkioAd04QW)
